Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness.

Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness.
复制标题

DOI:
10.1038/onc.2011.590
复制
发表时间:
2012-09-13
期刊:
影响因子:
8
通讯作者:
Pollack JR
Pollack JR
中科院分区:
医学1区
文献类型:
--
作者:
Huang S;Gulzar ZG;Salari K;Lapointe J;Brooks JD;Pollack JR

文献摘要

参考文献

被引文献

相似文献

虽然前列腺癌通常是无痛的,但它仍然是癌症死亡的主要原因。确定潜在的分子遗传改变可能会导致新的预防或治疗策略。为此,我们对86例原发性前列腺肿瘤进行了基于阵列的比较基因组杂交(CGH)。在与已知癌症基因无关的最常见的改变中,我们在86例病例中的15例(17%)中发现了5 q21内的局灶性缺失。通过高分辨率平铺阵列CGH,最小的共同缺失仅针对一个基因,染色质重塑染色体结构域解旋酶DNA结合蛋白1(CHD 1)。CHD 1在缺失型前列腺癌中的表达显著低于正常前列腺组织(P= 0.04),缺失型前列腺癌中CHD 1的表达显著低于正常前列腺组织(P= 0.03)。外显子测序分析还发现了7个细胞系中的1个(14%)(LAPC 4)和24个前列腺肿瘤中的1个(4%)的非同义突变。RNA干扰介导的敲除CHD 1在两个非致瘤性前列腺上皮细胞系,OPCN 2和RWPE-1,没有改变细胞生长,但促进细胞侵袭力,并在OPCN 2增强细胞克隆形成。综上所述,我们的研究结果表明,CHD 1缺失可能是前列腺癌细胞侵袭性的基础,并表明染色质重塑改变在前列腺肿瘤发生中可能的新作用。
Though prostate cancer is often indolent, it is nonetheless a leading cause of cancer death. Defining the underlying molecular genetic alterations may lead to new strategies for prevention or treatment. Towards this goal, we performed array-based comparative genomic hybridization (CGH) on 86 primary prostate tumors. Among the most frequent alterations not associated with a known cancer gene, we identified focal deletions within 5q21 in 15 out of 86 (17%) cases. By high-resolution tiling array CGH, the smallest common deletion targeted just one gene, the chromatin remodeler chromodomain helicase DNA-binding protein 1 (CHD1). Expression of CHD1 was significantly reduced in tumors with deletion (P=0.03), and compared with normal prostate (P=0.04). Exon sequencing analysis also uncovered nonsynonymous mutations in 1 out of 7 (14%) cell lines (LAPC4) and in 1 out of 24 (4%) prostate tumors surveyed. RNA interference-mediated knockdown of CHD1 in two nontumorigenic prostate epithelial cell lines, OPCN2 and RWPE-1, did not alter cell growth, but promoted cell invasiveness, and in OPCN2-enhanced cell clonogenicity. Taken together, our findings suggest that CHD1 deletion may underlie cell invasiveness in a subset of prostate cancers, and indicate a possible novel role of altered chromatin remodeling in prostate tumorigenesis.
DOI: 10.1016/j.ccr.2010.05.026
发表时间: 2010-07-13
期刊: Cancer cell
影响因子: 50.3
作者:
Taylor BS;Schultz N;Hieronymus H;Gopalan A;Xiao Y;Carver BS;Arora VK;Kaushik P;Cerami E;Reva B;Antipin Y;Mitsiades N;Landers T;Dolgalev I;Major JE;Wilson M;Socci ND;Lash AE;Heguy A;Eastham JA;Scher HI;Reuter VE;Scardino PT;Sander C;Sawyers CL;Gerald WL
通讯作者: Gerald WL
DOI: 10.1016/j.mrfmmm.2006.07.012
发表时间: 2007-05-01
影响因子: 2.3
作者:
Marfella, Concetta G. A.;Imbalzano, Anthony N.
通讯作者: Imbalzano, Anthony N.
DOI: 10.1073/pnas.0710052104
发表时间: 2007-12-11
影响因子: 11.1
作者:
Beroukhim, Rameen;Getz, Gad;Sellers, William R.
通讯作者: Sellers, William R.
DOI: 10.1038/nature08212
发表时间: 2009-08-13
期刊: Nature
影响因子: 64.8
作者:
Gaspar-Maia A;Alajem A;Polesso F;Sridharan R;Mason MJ;Heidersbach A;Ramalho-Santos J;McManus MT;Plath K;Meshorer E;Ramalho-Santos M
通讯作者: Ramalho-Santos M
DOI: 10.1210/me.2009-0421
发表时间: 2010-06-01
影响因子: --
作者:
Menon, Tushar;Yates, Joel A.;Bochar, Daniel A.
通讯作者: Bochar, Daniel A.